OK, given all that is ... FDA ... Patient advocates
We are sure, or pretty sure, the FDA won't back off as they
require more evidence but 2010?
Dew - is there any precedence which can put this on a faster track as 3 years seems harsh, after a company has spent over 400 million and was coming home with a drug that is sorely needed.
Is this really another GTC, or can we expect faster action in your opinion? A better question maybe, in your opinion
has DNDN shown efficacy. If so, then was DNDN somehow
negligent in being able to prove it. Or was it another GTC where the goalposts where moved after the game was in play?
OKY